IntrinsicIntrinsic

Cantor Equity Partners IV, Inc.

CEPF
🏒 Blank Checks

Business Operations Summary

Cantor Equity Partners IV, Inc. (CEPF) is a blank check company, also known as a Special Purpose Acquisition Company (SPAC), incorporated on April 30, 2021, in the Cayman Islands, with the sole purpose of effecting a business combination . The company does not currently have any operations or generate revenue, with its activities focused on identifying and completing a suitable acquisition . While not limited to a specific industry, CEPF is concentrating its search on companies within the financial services, digital assets, healthcare, real estate services, technology, and software industries .

The core business model of CEPF is to identify and acquire a target company, thereby providing an alternative to a traditional initial public offering for the acquired business. Revenue generation for CEPF will only commence after the completion of a business combination . The company aims to acquire a business with an aggregate fair market value of at least 80% of the assets held in its Trust Account at the time of signing a definitive agreement . Post-acquisition, the combined entity is expected to own or acquire 50% or more of the voting securities or a controlling interest in the target .

CEPF completed its Initial Public Offering (IPO) on August 22, 2025, selling 45,000,000 Class A ordinary shares at a price of $10.00 per share, raising gross proceeds of $450,000,000 . Concurrently, it sold 900,000 Private Placement Shares to the Sponsor at $10.00 per share, generating an additional $9,000,000 in gross proceeds . A total of $450,000,000 from the net proceeds of the IPO and Private Placement was placed in a Trust Account . As of December 31, 2025, the Trust Account held available-for-sale debt securities with a fair value of $456,710,724 and an amortized cost of $456,425,803 .

For the fiscal year ended December 31, 2025, CEPF reported net income of approximately $6,132,000 . This income was primarily derived from approximately $6,426,000 in interest income on investments held in the Trust Account. Operating expenses included approximately $250,000 in general and administrative expenses and approximately $44,000 in administrative expenses paid to a related party. In contrast, for the year ended December 31, 2024, the company reported a net loss of approximately $7,000 , consisting solely of general and administrative expenses . Basic and diluted net income per share for Class A Public shares, Class A Private Placement shares, and Class B Ordinary shares was $0.23 for the year ended December 31, 2025.

As of December 31, 2025, CEPF had cash of $25,000 in its operating account and working capital of approximately $60,000 . This compares to $0 cash and a working capital deficit of approximately $2,000 as of December 31, 2024. The company had approximately $6,711,000 of interest earned on funds in the Trust Account available to pay taxes as of December 31, 2025. Total assets as of December 31, 2025, were approximately $456,948,634 , significantly higher than approximately $306 as of December 31, 2024, reflecting the proceeds from the IPO and Private Placement. Total liabilities were $95,402 as of December 31, 2025, up from $2,188 in 2024. The company had approximately $31,000 outstanding under a Sponsor Loan as of December 31, 2025.

During the reported period, CEPF consummated its IPO on August 22, 2025, and simultaneously completed a private placement of shares to its Sponsor . The company also engaged CF&Co., an affiliate of the Sponsor, as an advisor for the business combination, with a cash fee of $16,750,000 payable upon consummation of the Business Combination . The company also incurred approximately $8,600,000 in offering costs, including $8,000,000 in underwriting fees and $100,000 to a qualified independent underwriter .

Business Outlook & Future Growth Drivers

CEPF's primary objective for the upcoming period is to identify and consummate a Business Combination by August 22, 2027 , or an earlier or later date as approved by the Board or shareholders, respectively. The company is focusing its search on target companies in the financial services, digital assets, healthcare, real estate services, technology, and software industries . Management anticipates favoring potential target companies with positive long-term growth prospects, competitive advantages, consolidation opportunities, recurring revenue or the potential for recurring revenue, opportunities for operational improvement, and attractive margins or the potential for attractive margins .

The company's acquisition strategy leverages the network and expertise of its management team, the Sponsor, and its affiliates in sourcing, structuring, acquiring, and selling businesses, fostering relationships, negotiating transactions, accessing capital markets, operating companies, and expanding product ranges and geographic footprints . CEPF believes its structure as a public company offers target businesses an attractive alternative to traditional IPOs, providing greater access to capital and means for management incentives aligned with shareholder interests .

In terms of financial trajectory, CEPF expects to have sufficient working capital and borrowing capacity from the Sponsor to meet its needs through the earlier of the consummation of the Business Combination or one year from the date of the Report . These funds will be allocated towards paying existing accounts payable, identifying and evaluating prospective target businesses, performing due diligence, covering travel expenditures, and structuring, negotiating, and consummating the Business Combination . The company will continue to generate non-operating income from interest on funds held in the Trust Account .

CEPF plans to fund the Business Combination using a combination of cash remaining in the Trust Account, net proceeds from the sale of its securities, shares issued to target owners, and net proceeds from debt issued to lenders or target owners . The Sponsor has committed to loan CEPF up to $1,750,000 through the Sponsor Loan to cover expenses related to investigating and selecting a target business and other working capital requirements . This loan does not bear interest and is repayable upon the consummation of the Business Combination, with an option for conversion into Class A ordinary shares at $10.00 per share .

The company is monitoring developments related to the SEC's 2024 SPAC Rules, which may materially affect its ability to negotiate and complete a Business Combination and could increase associated costs and time . Additionally, the SEC's rules on climate-related disclosures, if implemented, may significantly increase the complexity of periodic reporting for a U.S. public company .

Major Risk Factors & Challenges

CEPF faces several material risks, including the inherent uncertainty of being a blank check company with no operating history or revenue, and the potential inability to select an appropriate target business and complete a Business Combination within the Combination Period, which extends to August 22, 2027 . There is a risk that expectations regarding the performance of a prospective target business may not be realized, and the company may not be successful in retaining or recruiting key personnel post-Business Combination. Conflicts of interest may arise due to officers and directors allocating time to other businesses or having financial interests in the Sponsor, which could incentivize them to complete a transaction even if it is unprofitable for Public Shareholders . The funds in the Trust Account may not be fully protected against third-party claims or bankruptcy, and the Sponsor's indemnification obligations are not guaranteed to be satisfied . The company may also face increased competition from other SPACs, potentially leading to higher acquisition costs or an inability to find a suitable target. Geopolitical conditions, such as the Russia-Ukraine conflict and Middle East conflicts, and other disruptions to capital markets, including inflation, could adversely affect the company's ability to consummate a Business Combination . Regulatory review and approval requirements, including foreign investment regulations, could also impede the completion of a Business Combination, and an Excise Tax may be imposed on redemptions of Public Shares in connection with a Business Combination involving a U.S. target .

Management Priorities & Sentiments

Management's message emphasizes the company's strategic focus on leveraging the extensive experience of its management team, the Sponsor, and its affiliates in identifying and acquiring a suitable target business. The company's strategic priorities include focusing its search on companies in the financial services, digital assets, healthcare, real estate services, technology, and software industries, and seeking targets with positive long-term growth prospects, competitive advantages, and opportunities for operational improvement and attractive margins. Management believes that its structure as a public company offers a compelling alternative for target businesses to access capital and align management incentives. The company has until August 22, 2027 , to consummate a Business Combination, and management believes it has sufficient working capital and borrowing capacity from the Sponsor to meet its needs through this period .

References

  1. [1] Item 1, Business β€” Introduction
  2. [2] Item 7, MD&A β€” Results of Operations
  3. [3] Item 1, Business β€” Introduction
  4. [4] Item 7, MD&A β€” Results of Operations
  5. [5] Item 1, Business β€” Business Combination
  6. [6] Item 1, Business β€” Business Combination
  7. [7] Item 1, Business β€” Initial Public Offering
  8. [8] Item 1, Business β€” Initial Public Offering
  9. [9] Item 1, Business β€” Initial Public Offering
  10. [10] Item 8, Balance Sheets β€” Available-for-sale debt securities held in Trust Account, at fair value
  11. [11] Item 8, Balance Sheets β€” Available-for-sale debt securities held in Trust Account, at fair value (amortized cost)
  12. [12] Item 7, MD&A β€” Results of Operations
  13. [13] Item 7, MD&A β€” Results of Operations
  14. [14] Item 7, MD&A β€” Results of Operations
  15. [15] Item 7, MD&A β€” Results of Operations
  16. [16] Item 7, MD&A β€” Results of Operations
  17. [17] Item 7, MD&A β€” Results of Operations
  18. [18] Item 8, Statements of Operations β€” Basic and diluted net income (loss) per share: Class A – Public shares, Class A – Private placement, Class B – Ordinary shares
  19. [19] Item 7, MD&A β€” Liquidity and Capital Resources
  20. [20] Item 7, MD&A β€” Liquidity and Capital Resources
  21. [21] Item 7, MD&A β€” Liquidity and Capital Resources
  22. [22] Item 7, MD&A β€” Liquidity and Capital Resources
  23. [23] Item 7, MD&A β€” Liquidity and Capital Resources
  24. [24] Item 8, Balance Sheets β€” Total Assets
  25. [25] Item 8, Balance Sheets β€” Total Assets
  26. [26] Item 8, Balance Sheets β€” Total Liabilities
  27. [27] Item 8, Balance Sheets β€” Total Liabilities
  28. [28] Item 7, MD&A β€” Contractual Obligations
  29. [29] Item 7, MD&A β€” Overview
  30. [30] Item 7, MD&A β€” Contractual Obligations
  31. [31] Item 7, MD&A β€” Contractual Obligations
  32. [32] Item 1, Business β€” Initial Public Offering
  33. [33] Item 13, Certain Relationships and Related Transactions, and Director Independence
  34. [34] Item 13, Certain Relationships and Related Transactions, and Director Independence
  35. [35] Item 13, Certain Relationships and Related Transactions, and Director Independence
  36. [36] Item 1, Business β€” Initial Public Offering
  37. [37] Item 1, Business β€” Introduction
  38. [38] Item 1, Business β€” Investment Criteria
  39. [39] Item 1, Business β€” Business Strategy
  40. [40] Item 1, Business β€” Status as a Public Company
  41. [41] Item 7, MD&A β€” Liquidity and Capital Resources
  42. [42] Item 7, MD&A β€” Liquidity and Capital Resources
  43. [43] Item 7, MD&A β€” Results of Operations
  44. [44] Item 1, Business β€” Effecting the Business Combination
  45. [45] Item 7, MD&A β€” Liquidity and Capital Resources
  46. [46] Item 7, MD&A β€” Liquidity and Capital Resources
  47. [47] Item 7, MD&A β€” Contractual Obligations
  48. [48] Item 7, MD&A β€” Overview
  49. [49] Item 7, MD&A β€” Overview
  50. [50] Item 1A, Risk Factors
  51. [51] Item 1A, Risk Factors
  52. [52] Item 1A, Risk Factors
  53. [53] Item 1A, Risk Factors
  54. [54] Item 1A, Risk Factors
  55. [55] Item 1, Business β€” Initial Public Offering
  56. [56] Item 7, MD&A β€” Liquidity and Capital Resources

Report on May 20, 2026